Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse, Rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Multiple synthetic peptides corresponding to the C-terminal and N-terminal domains of human CDK9.|
|Storage buffer||whole serum diluted in PBS|
|Contains||0.01% sodium azide|
|Storage Conditions||4°C or -20°C if preferred|
|Tested Applications||Dilution *|
|ELISA (ELISA)||1/10,000 - 1/50,000|
|Immunohistochemistry (Paraffin) (IHC (P))||1:200-1:1000|
|Immunoprecipitation (IP)||Assay Dependent|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA1-84581 does not cross-react with other cyclin dependent kinases.
CDK9, previously named PITALRE, is a 43 kDa member of the cyclin-dependent protein kinase (CDK) family and is located primarily in the nucleus. Unlike most cdc2-like kinases, it does not appear to be cycle-regulated.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
C-2k; CDC2-related kinase; CDC2L4; cell division cycle 2-like protein kinase 4; cell division protein kinase 9; CTK1; cyclin-dependent kinase 9; cyclin-dependent kinase 9 (CDC2-related kinase); PITALRE; RP11-228B15.5; serine/threonine protein kinase PITALRE; TAK; tat-associated kinase complex catalytic subunit
C-2k; CDC2L4; CDK9; CTK1; PITALRE; TAK